Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
Operating Expenses | 3,769 | 3,817 | 5,370 | 7,478 | 8,190 |
Operating Income | -3,769 | -3,817 | -5,370 | -7,478 | -8,190 |
Other Income | 46 | 26 | 15 | 8 | 16 |
Pre-tax Income | -3,723 | -3,791 | -5,355 | -7,470 | -8,174 |
Net Income Continuous | -3,723 | -3,791 | -5,355 | -7,470 | -8,174 |
Net Income | $-3,723 | $-3,791 | $-5,355 | $-7,470 | $-8,174 |
EPS Basic Total Ops | -13.21 | -16.81 | -24.61 | -35.41 | -39.62 |
EPS Basic Continuous Ops | -13.10 | -17.02 | -24.86 | -35.51 | -39.54 |
EPS Diluted Total Ops | -13.21 | -16.81 | -24.61 | -35.41 | -39.62 |
EPS Diluted Continuous Ops | -13.10 | -17.02 | -24.86 | -35.51 | -39.54 |
EBITDA(a) | $-3,768 | $-3,816 | $-5,369 | $-7,477 | $-8,189 |